Skip to main content
Caplight Logo









Nodus Oncology

Nodus Oncology

Private
EdinburghHealthcare & Life Scienceshttps://nodusoncology.com

Last Round

Seed

Jan 11, 2024

Total Funding Raised

$5.2M

Company Overview

Nodus Oncology operates in Healthcare & Life Sciences and is based in Edinburgh. Its latest recorded funding round was a Seed round in January 2024.

Nodus Oncology is a biotechnology company that develops small molecule therapeutics targeting DNA damage response pathways for cancer treatment.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Nodus Oncology Comparables

Compare Nodus Oncology with similar companies based on industry and business-model similarity.

Nodus Oncology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Azkarra Therapeutics
86%
FoRx Therapeutics
86%
Artios Pharma
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Nodus Oncology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 11, 2024
SeedFeb 7, 2023
SeedSep 6, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 11, 2026

    Monthly visitors increased 57% MoM.

  • Jan 19, 2026

    Monthly visitors increased 44% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Nodus Oncology Filings

Explore SEC and related filing metadata, where available.

Nodus Oncology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Nodus Oncology's valuation, stock price, and market status.

Is Nodus Oncology a public or private company?

Nodus Oncology is a private company.

What is the current stock price of Nodus Oncology?

Nodus Oncology is a private company, so its shares have no public market price. Caplight tracks Nodus Oncology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Nodus Oncology worth (valuation)?

Valuation information for Nodus Oncology is not publicly available.

Can I buy Nodus Oncology stock?

Nodus Oncology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Nodus Oncology's last funding round?

Nodus Oncology's most recent funding round was Seed on January 11, 2024.

Who are the main investors in Nodus Oncology?

Investor information for Nodus Oncology is not publicly disclosed.

Will Nodus Oncology IPO soon?

No public IPO plans have been announced for Nodus Oncology.

How can I track Nodus Oncology secondary market activity?

Caplight tracks bids, offers, and trades in Nodus Oncology's shares on secondary markets.

Firmographic Details

HeadquartersEdinburgh
Employee Range3
Year Founded2022
Last FundingJan 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?